Evolent Health, Inc.

Fundamentals3.0
Price Action7.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Breakeven Trend
  • High Leverage
  • Weak Returns

AI
AI Summary

5.0

EVH has moved from a structurally impaired healthcare name to a credible turnaround candidate after its latest quarter showed near-breakeven operating performance and slight EBITDA positivity, but the rally is only actionable if that margin improvement proves durable and converts into consistent free cash flow despite high leverage and thin liquidity.

Turnaround
CashFlow
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

3.0

Key Financial Insights:

  • Breakeven Trend
  • High Leverage
  • Weak Returns

EVH is moving closer to breakeven after a very weak FY2025, but high leverage, thin liquidity, and deeply negative returns still make the turnaround risky despite low valuation multiples.

turnaround
leverage

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Higher highs
  • Breakout support
  • Near-term resistance

EVH has been in a strong uptrend over the last month, breaking above the $4.48–$5.03 zone, but near-term upside now looks capped near $5.77 unless it holds support and avoids a pullback toward $5.42/$5.03.

bullish
watch
Support Level: $5.42, then $5.03
Resistance Level: $5.77

Fast rally from early

Sentiment & News

6.0

Key News Insights:

  • Rally Follow-through
  • Bullish Technicals
  • Analyst Upgrades

EVH is showing strengthening short-term momentum as a post-earnings rally, improving analyst sentiment, and a bullish golden cross suggest the stock may be building toward a more constructive trend.

Momentum
GoldenCross

This news is likely supportive for EVH in the near term, as improving price action and technical confirmation can attract additional momentum buyers